Axsome Therapeutics, Inc.
AXSM
13 insider filings · Latest: Jun 10, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jun 11, 2026 | Jun 12 12:34 AM | Roger JeffsDirector | Sale | 286 | $249.12 | $71.2K | 58,367(D) | View → |
| Jun 10, 2026 | Jun 12 12:34 AM | Roger JeffsDirector | Sale | 286 | $246.18 | $70.4K | 58,653(D) | View → |
| Jun 10, 2026 | Jun 11 1:49 AM | Susan MahonyDirector | Sale | 300 | $246.18 | $73.9K | 829(D) | View → |
| Jun 9, 2026 | Jun 11 1:49 AM | Susan MahonyDirector | Sale | 300 | $237.21 | $71.2K | 1,129(D) | View → |
| Jun 10, 2026 | Jun 11 1:49 AM | Mark ColemanDirector | Sale | 643 | $249.00 | $160.1K | 30,389(D) | View → |
| Jun 9, 2026 | Jun 9 9:17 PM | TABUTEAU HERRIOTDirector, Chief Executive Officer, 10% Owner | Sale | 49,670 | $241.01 | $12.0M | 7,229(D) | View → |
| Jun 9, 2026 | Jun 9 9:17 PM | Nick PizzieChief Financial Officer | Sale | 33,000 | $240.09 | $7.9M | 42,867(D) | View → |
| Jun 2, 2026 | Jun 2 11:00 PM | Mark ColemanDirector | Sale | 5,537 | $223.39 | $1.2M | 29,603(D) | View → |
| Jun 1, 2026 | Jun 2 11:00 PM | Mark ColemanDirector | Sale | 6,000 | $230.30 | $1.4M | 35,140(D) | View → |
| May 29, 2026 | Jun 2 11:00 PM | Mark ColemanDirector | Sale | 6,000 | $233.46 | $1.4M | 41,140(D) | View → |
| May 5, 2026 | May 6 12:34 AM | Mark L. JacobsonChief Operating Officer | Sale | 233 | $228.18 | $53.2K | 0(D) | View → |
| May 4, 2026 | May 6 12:34 AM | Mark L. JacobsonChief Operating Officer | Sale | 4,517 | $227.94 | $1.0M | 0(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jun 8, 2026 | Jun 11 1:49 AM | Roger JeffsDirector | Option Exercise | 1,429 | — | 0(D) | View → |
| Jun 8, 2026 | Jun 11 1:49 AM | Mark E SaadDirector | Option Exercise | 1,429 | — | 0(D) | View → |
| Jun 8, 2026 | Jun 11 1:49 AM | Susan MahonyDirector | Option Exercise | 1,429 | — | 0(D) | View → |
| Jun 8, 2026 | Jun 11 1:49 AM | Mark ColemanDirector | Option Exercise | 1,429 | — | 0(D) | View → |
| Jun 5, 2026 | Jun 9 9:18 PM | Mark ColemanDirector | Grant/Award | 1,721 | — | 1,721(D) | View → |
| Jun 5, 2026 | Jun 9 9:18 PM | Susan MahonyDirector | Grant/Award | 1,721 | — | 1,721(D) | View → |
| Jun 9, 2026 | Jun 9 9:17 PM | TABUTEAU HERRIOTDirector, Chief Executive Officer, 10% Owner | Option Exercise | 49,670 | $241.01 | 99,330(D) | View → |
| Jun 9, 2026 | Jun 9 9:17 PM | Nick PizzieChief Financial Officer | Option Exercise | 33,000 | $3.50 | 72,000(D) | View → |
| Jun 5, 2026 | Jun 9 9:16 PM | Mark E SaadDirector | Grant/Award | 1,721 | — | 1,721(D) | View → |
| Jun 5, 2026 | Jun 9 9:15 PM | Roger JeffsDirector | Grant/Award | 1,721 | — | 1,721(D) | View → |
| May 5, 2026 | May 6 12:34 AM | Mark L. JacobsonChief Operating Officer | Option Exercise | 233 | $12.95 | 114,954(D) | View → |
| May 4, 2026 | May 6 12:34 AM | Mark L. JacobsonChief Operating Officer | Option Exercise | 4,517 | $12.95 | 115,187(D) | View → |